NOVEN PHARMACEUTICALS INC Administration Agreements
4 Contracts & Agreements
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
- Daytrana, the first and only transdermal patch approved by the United States Food & Drug Administration (FDA) for the treatment of ADHD (Filed With SEC on March 13, 2009)
